EVQLV Media

Brett Averso on the AI Podcast in 26.1 Minutes

Brett Averso on the AI Podcast in 26.1 Minutes

Our very own Brett Averso (CTO, EVQLV) was welcomed on the AI Podcast in 26.1 Minutes with hosts Brian Ray and Don Sheu. They discussed our work on COVID-19 with ImmunoPrecise, the benefits of a computational approach to antibody research and drug discovery, our progress as a company and a host of other topics.

read more
EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV Submits First Panel of Optimized Antibody Sequences

EVQLV, has submitted their first panel of candidate therapeutic antibody sequences, comprised of DNA sequences encoding for potentially therapeutic antibodies against the new coronavirus, SARS-CoV-2. These DNA sequences were generated using computational antibody design, a method which combines mathematics, statistics, and computer science to identify high-affinity antibodies.

read more
Coronavirus Visualized

Coronavirus Visualized

Brett Averso, CTO, and I recently had a follow up discussion on our first coronavirus chat. Brett provided visualizations and commentary on coronavirus (SARS-CoV-2), ACE2, SARS-CoV-2 with SARS overlay, and antibody fragments to help people better understand the threat we’re currently facing, as well as put it in its proper context. Brett also discussed the role AI can play in finding an effective treatment for COVID-19.

read more

Pin It on Pinterest